首页>
外文期刊>Journal of Health, Medicine and Nursing
>In Vivo Analysis of Therapeutic Effects of Hydroxychloroquine, Azithromycin, Paracetamol, Dexamethasone, Remdesivir and Tocilizumab in Patients Affected with Novel Covid-19
【24h】
In Vivo Analysis of Therapeutic Effects of Hydroxychloroquine, Azithromycin, Paracetamol, Dexamethasone, Remdesivir and Tocilizumab in Patients Affected with Novel Covid-19
COVID 19 creates pandemic around the globe. This virus spread so rapidly and unfortunately till now there is no authentic treatment available. Based upon the trials various drugs were applied to control the disease. Different drugs found effective including hydroxychloroquine, dexamethasone, azithromycin and remdesivir. In current study 100 patients were participated. The presence of disease was confirmed by PCR based tests. Initials reports represent various abnormal range of WBC’s in patients. Most of them were symptomatic while few were asymptomatic. Gender wise COVID-19 mostly affected males rather than female gender. It was also found that older person were more susceptible than younger one.Effectiveness of the drugs shows there is need to do more work on following components to control the disease prevalence until a vaccine is discovered.
展开▼